BG Medicine (BGMD) Misses Q1 EPS by 1c

Go back to BG Medicine (BGMD) Misses Q1 EPS by 1c

BG Medicine Reports First Quarter 2015 Financial Results

May 14, 2015 7:45 AM EDT

Net Loss Reduced by 38% and Operating Cash Burn Cut by 42% from First Quarter 2014

Outlook Improved for 2015

WALTHAM, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq: BGMD), the developer of the BGM Galectin-3® Test, today reported... More

BG Medicine Reports First Quarter 2015 Financial Results

May 14, 2015 7:45 AM EDT

Net Loss Reduced by 38% and Operating Cash Burn Cut by 42% from First Quarter 2014

Outlook Improved for 2015

WALTHAM, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq: BGMD), the developer of the BGM Galectin-3® Test, today reported... More